Complex rearrangement involving 9p deletion and duplication in a syndromic patient : Genotype/phenotype correlation and review of the literature by M.P. Recalcati et al.
Gene 502 (2012) 40–45
Contents lists available at SciVerse ScienceDirect
Gene
j ourna l homepage: www.e lsev ie r .com/ locate /geneShort Communication
Complex rearrangement involving 9p deletion and duplication in a syndromic
patient: Genotype/phenotype correlation and review of the literature
Maria Paola Recalcati a,⁎, Melissa Bellini b, Lorenzo Norsa b, Lucia Ballarati a, Rossella Caselli a, Silvia Russo a,
Lidia Larizza a,c, Daniela Giardino a
a Laboratorio di Citogenetica Medica e Genetica Molecolare, IRCCS Istituto Auxologico Italiano, Milan, Italy
b Clinica Pediatrica, A.O. San Paolo, Università di Milano, Milan, Italy
c Dipartimento di Medicina, Chirurgia e Odontoiatria, A.O. San Paolo, Università di Milano, Milan, ItalyAbbreviations: Array-CGH, Array based comparative
Fluorescent in situ hybridization; OFC, Occipitofrontal
artiﬁcial chromosome; dUTP, Deoxyuridine triphosph
Diethylaminocoumarine; PCR, Polymerase chain react
dependent probe Ampliﬁcation; UCSC Genome Brow
Santa Cruz Genome Browser; DMRT gene, Doublesex an
factor; DOCK8 gene, Dedicator of cytokinesis 8; KANK
and ankyrin repeat domains 1; SLC1A1 gene, Solute car
gene, Glycine dehydrogenase.
⁎ Corresponding author at: Laboratorio di Citogenetica
IRCCS Istituto Auxologico Italiano, via Zucchi 18, 200
Tel.: +39 02 619112416; fax: +39 02 619112464.
E-mail address: p.recalcati@auxologico.it (M.P. Reca
0378-1119/$ – see front matter © 2012 Elsevier B.V. Al
doi:10.1016/j.gene.2012.04.030a b s t r a c ta r t i c l e i n f oArticle history:
Accepted 9 April 2012
Available online 17 April 2012
Keywords:





Phenotype–genotype correlationWe describe a 7-year-old boy with a complex rearrangement involving the whole short arm of chromosome
9 deﬁned by means of molecular cytogenetic techniques. The rearrangement is characterized by a 18.3 Mb
terminal deletion associated with the inverted duplication of the adjacent 21,5 Mb region. The patient
shows developmental delay, psychomotor retardation, hypotonia. Other typical features of 9p deletion
(genital disorders, midface hypoplasia, long philtrum) and of the 9p duplication (brachycephaly, down slant-
ing palpebral ﬁssures and bulbous nasal tip) are present. Interestingly, he does not show trigonocephaly that
is the most prominent dysmorphism associated with the deletion of the short arm of chromosome 9. Patient's
phenotype and the underlying ﬂanking opposite 9p imbalances are compared with that of reported patients
and the proposed critical regions for 9p deletion and 9p duplication syndromes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Chromosome 9 short arm monosomy and trisomy are syndromic
conditions with peculiar clinical phenotypes, consequent to complete
or partial 9p deletions/duplications.
Both 9p deletions and duplications are associated with mental
and psychomotor retardation, hypotonia, hypertelorism and skeletal
malformations. In addition, 9p deletion carriers show variable
genital and/or gonadal disorders if XY patients, trigonocephaly, mid-
face hypoplasia, small and up slanting palpebral ﬁssures, long phil-
trum (Christ et al., 1999; Kawara et al., 2006; Swinkles et al., 2008).
Conversely 9p duplication carriers present with microcephaly/
brachycephaly, down slanting palpebral ﬁssures, bulbous nasal
tip, short philtrum and short neck (Fujimoto et al., 1998; Jelingenomic hybridization; FISH,
circumference; BAC, Bacterial
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l rights reserved.et al., 2010; Zou et al., 2009). However, a great clinical heterogeneity
is observed depending on the 9p genomic regions involved in the
rearrangements. Due to this variability the precise molecular charac-
terization of the unbalanced regions is an important tool to: (1) deep-
en the correlation between 9p deleted or duplicated genomic regions
and phenotypic features, (2) deﬁne critical minimum overlap regions
for the phenotype to reﬁne or conﬁrm those that have been proposed,
(3) provide an “ad hoc” genetic counseling.
We present a 7-year-old male patient with an inverted duplication
and a terminal deletion of the short arm of chromosome 9.
The rearrangement has been ﬁnely characterized by array-based
Comparative Genomic Hybridization (array-CGH) and Fluorescent
In Situ Hybridization (FISH). Moreover we address the correlation be-
tween the patient's clinical manifestations and the regions involved
in the rearrangement by comparison to the clinical presentation and
the 9p genomic imbalances of other reported cases.
2. Materials and methods
2.1. Clinical description
The patient is a 7 years old Caucasian boy, showing developmental
delay and craniofacial anomalies. He is the ﬁrst child of non-
consanguineous parents with an unremarkable family history for ge-
netic disorders. Prenatal ultrasound monitoring revealed macrosomy.
Pregnancy and delivery were normal. At birth he presented a duode-
nal stenosis, surgically corrected. In his ﬁrst year of life he showed
Fig. 1. Diagram showing the patient's main facial dysmorphisms.
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tium secundum interatrial defect and developmental delay.
Our clinical evaluation at 7 years of age revealed hypotonia and
ataxia, brachycephaly, asymmetric, round and ﬂat face with hypoplasic
midface, hypertelorism, strabismus, wide nasal bridge and bulbous
nose, long and smooth philtrum, thin upper lip, open mouth appear-
ance, high-arched palate and low-set ears (Fig. 1 and Supplementary
Fig. 1). Short neck, pectus carinatum, heart murmur, wide-spaced nip-
ples and dorso lumbar scoliosis were also noted; testicles spontaneous-
ly descended and no hypospadias was present. Auxological data were
the following: weight and length 25th-50th percentile and OFC 75th
percentile. Blood analyses for hematochemical parameters, thyroid
function and metabolic disorders screening provided normal results.
Abdominal ultrasound also showed normal patterns. In order to better
characterize the neurological involvement, a specialist examination
was performed which evidenced a severe developmental delay. Elec-
troencephalogram was normal while cerebral magnetic resonance
showed the presence of hypoplasia of corpus callosum and brain-stem.2.2. Cytogenetic and Fluorescent In Situ Hybridisation (FISH) Analysis
Cytogenetic analysis was performed on peripheral blood lympho-
cytes from the patient and his mother (father not available) usingFig. 2. Cytogenetic characterization of rearranged 9p. (a) Q-banded partial karyotype of the p
gram (left) and magniﬁcation of the anomalous array-CGH proﬁle (right): green dots repre
with probes RP11-3J10 (red signal) and RP11-108C23 (blue signal). The hybridization patt
The co-hybridization signals given by RP11-108C23 BAC probe are visible on the 9q pericenQFQ banding techniques on metaphase chromosomes obtained by
standard procedures. The karyotype was described in accordance
with ISCN 2009 (Shaffer and Slovak, 2009). The BAC probes used in
the FISH study were selected according to the University of California,
Santa Cruz (UCSC) Genome Browser (release March 2006) and pro-
vided by Prof. Mariano Rocchi (University of Bari, Italy). BAC probes
were nick translation labelled with biotin-dUTP (La Roche) or Cy3-
dUTP (Amersham), and detection of biotin-dUTP labelled probe
made by DEAC-streptavidin. The standard FISH protocol was followed
with minor modiﬁcations (Lichter and Cremer, 1992).
2.3. High resolution array comparative genomic hybridization
(array-CGH) analysis
Genomic DNA was puriﬁed from peripheral blood mononucleate
cells by using the GenElute™ Blood Genomic DNA kit (Sigma-Aldrich)
according to the supplier's instructions. Array-CGH was performed
by using the 244 K Human Genome CGH Microarray Kit (Agilent,
Santa Clara, CA) with a mean resolution of ~50 kb. Protocol provided
by Agilent has been followed with no modiﬁcations. The arrays were
analyzed with the Agilent Scanner Control (v 7.0) and the Feature Ex-
traction software (v 9.5.1). Graphical overviews were obtained using
the CGH Analytic software (v4.0.81). Nucleotide designations were
assigned according to the hg18 build of the human genome.
2.4. Microsatellites analysis
Segregation analysis of polymorphic loci was performed on patient
and his mother (father not available) using microsatellites mostly
spanning the chromosome 9 deleted and duplicated regions. The fol-
lowing polymorphic markers were used: D9S1813, D9S286, D9S157,
D9S169, D9S1817, D9S1791, D9S1799, D9S167, D9S1872. Primers
sequences and positions are available on UCSC Genome Browser
(release March 2006; http://genome.ucsc.edu/cgi-bin/hgGateway).
Polymerase chain reaction (PCR) assays were developed and
optimized to amplify each fragment containing a marker of
interest in a 15-μl volume using TaqGold 0.15 u (Biorad, Hercules,
CA) and GeneAmp PCR Gold Buffer 10× (Biorad, Hercules, CA) with
50–100 ng DNA and 0.1 μM each primer. Final products were pre-
pared for injection on the ABI PRISM 310 Genetic Analyzer (Applied
Biosystems, Foster City, CA), using deionized formamide, 0.5 μl GSropositus, showing the derivative chromosome 9 on the right; b) Chromosome 9p ideo-
sent deletion and red dots duplication. Breakpoints are indicated; c) Dual-colour FISH
ern on derivative chromosome 9 (arrowed) indicates that the duplication is inverted.
tromeric region of both chromosomes 9.
Table 1
Segregation pattern of polymorphic loci analysed for patient and his mother (father
alleles are deduced). Bolding indicates informative loci.
Locus Chromosome
band
Position Father Patient Mother
D9S1813 9p24.2 4,023,584–4,223,960 ?/? -/A1 A1- A2
D9S286 9p24.1 7,943,378–8,143,709 ?/? -/A1 A1- A2
D9S157 9p22.2 17,518,219–17,718,591 ?/? -/A2 A2- A1
D9S169 9p21.2 27,128,617–27,329,008 ?/A2 A2-A2/A1 A1- A3
D9S1817 9p13.3 33,749,593–33,949,887 ?/A1 A1-A1/A2 A2- A2
D9S1791 9p13.3-13.2 36,283,375–36,483,713 ?/A1 A1-A1/A3 A3- A2
D9S1799 9q21.1 72,456,672–72,657,036 ?/A3 A3- A2 A2- A1
D9S167 9q21.32 84,873,828–85,074,162 ?/A2 A2- A1 A1- A3
D9S1872 9q33.1 120,729,316–120,929,460 ?/A1 A1- A2 A2- A3
42 M.P. Recalcati et al. / Gene 502 (2012) 40–45ROX500 size standard (Applied Biosystems, Foster City, CA) and 1.0 μl
PCR products. Products were separated by POP4 and analyzed by
GeneScan.3. Results
The QFQ-banding analysis revealed the presence of one chro-
mosome 9 abnormal in the short arm (Fig. 2a); to exclude any
low rate mosaicism the analysis has been extended to 100 mito-
ses. Array-CGH analysis identiﬁed an 18.3 Mb 9p terminal deletion
(breakpoint at 9p22.2) and a 21.5 Mb duplication of the adjacent
region with telomeric breakpoint at 9p22.2 and centromeric
breakpoint at 9p13.1 (Fig. 2b). Double colour FISH with BAC
probes RP11-3J10 (located at 9p13.2) and RP11-108C23 (locatedFig. 3. 9p24.3p12 map showing regions involved in our patient's rearrangement, compared
tial duplications, 9p isolated partial deletions and a mosaic supernumerary 9p chromosome
by green and red bars: distance (Mb) from the 9p telomere is indicated. Dotted lines repre
region for genital/gonadal disorders in the context of 9p deletion; blue and violet bars illu
9p duplication syndrome, respectively. The proposed critical region for speech delay associat 9p11.2 and co-hybridizing to the pericentromeric region of
chromosome 9q) allowed us to establish that the duplication
also encompasses the 9p11.2 band and is an inverted duplication
(Fig. 2c). The proband's karyotype could thus be deﬁned as 46,XY,
der(9)del(9)(p22)dup(9)(p22p11.2).ish dup(9)(p13.2p11.2)(RP11-
3J10++,RP11-108C23++).arr 9p24.3p22.2(194,193-18,341,167)x1,
9p22.2p13.1(18,368,491-39,884,938)x3. The cytogenetic and array-
CGH analyses of the proband's mother gave normal results, while
the father was not available.
Microsatellites analysis was carried on DNAs from the patient and
his mother using markers located into the deleted and duplicated re-
gions. Informative markers allowed us to deduce the paternal origin
of the rearrangement: unbalanced ratio between areas of paternal
and maternal allele peaks was indicative of a double contribute
from the father in the duplicated region previously identiﬁed by
array-CGH analysis. Table 1 shows the observed segregation pattern.4. Discussion
Here we present a male patient carrying an abnormal short arm
of chromosome 9 identiﬁed by QFQ banding and subsequently
reﬁned by array-CGH and FISH as a complex rearrangement with a
9p24.3p22.2 terminal deletion and an adjacent 9p22.2p11.2 inverted
duplication. Microsatellites analysis allowed us to deduce that rear-
rangement in the patient occurred on chromosome 9 inherited from
the father.
In Fig. 3 our patient's unbalanced regions are compared to previ-
ously reported cases of 9p duplications with associated deletions, 9pto molecularly characterized 9p deletions with associated duplications, 9p isolated par-
reported in the literature. Deleted and duplicated regions are represented respectively
sent undeﬁned deletions/duplications end regions. Light blue bar refers to the critical
strate the critical regions for the consensus phenotypes of 9p deletion syndrome and
ated with 9p duplication is represented by the pink bar. CR: critical region.
Table 2
Presence (+), absence (−) or mild manifestation (+/−) of 9p deletion and duplication syndromes recurrent features in the present case and in cases from the literature (nk, not known).
Deletion and duplication Isolated duplications/marker Isolated deletions












Kawara [3] Ogata [9]
(XY) (XX) (XX) (XX) (XY) (XY) (XX) (XY) (XY)
9p deleted region 9p24.3p22.2 9p24.3p24.2 9p24.3p22.2 9p24.3p22.3 9p24.3p23 9p24.3p22.3 9p24.3p22.3 9p23p22.2 9p24.3p?24.1
9p duplicated region 9p22.2p12 9p24.2p21.3 9p22.2p13.3 9p22.3p12 9p24.3p13.1 9p24.3p21.1 9p21.3p13.2 9p22.39p21.1 9p?23p22.1
9p deletion/duplication
features
Developmental delay + + + + + + + − + + + + + −
Psychomotor retardation + + + + + + + − + + + + + −
Hypotonia + + + + − − − − nk + − + nk −
Hypertelorism + + − − − − − − − − − − + −
Low-set and posteriorly
angulated ears
+ + + + − + − − + + + + + +
Skeletal malformations + − + − − + + − − − +/− +/− − +
9p deletion features
Trigonocephaly − − + + − + − + −
Midface hypoplasia + + + +/− − + + + −
Up slanting palpebral
ﬁssures
− − − + − + − + −
Short palpebral ﬁssures − − + + − +/− + + −
Anteverted nostrils − − + + − − + + +
Long philtrum + + + +/− + + − + −
Thin upper lip + + + + − + + + −
Micrognathia − + + + − + − − +
Short/broad neck + − + − + + + nk −
Cardiac defects + − + + − − − + −
Genital/gonadal disorders + − − − + − − + +
Inguinal hernia + − − − − + + − −
Omphalocele − − + − − − − − −
9p duplication features
Speech/language delay + nk + + + + + + +
Growth retardation/
short stature
− + + + + nk + − +
Microcephaly/
Brachycephaly
+ − − − + + − − +
Deep and wide-set eyes − + − − + − − − −
Down slanting palpebral
ﬁssures
+ − − − − − − − +
Bulbous nasal tip + + + + − + + + +
Short philltrum − − − − − + + + −
Downturned corners
of the mouth
− + − − − − − − +
Highly arched palate + − + + − − − + +
Cleft palate/lip − + − − − + − − −
Toes with short/
distrophyc nails
− + − − − nk nk − −
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characterized by array-CGH, FISH, Multiple Ligation-Dependent
Probe Ampliﬁcation (MLPA) or microsatellites analysis. The pheno-
types of the patients at comparison, each identiﬁed by his/her 9p
rearrangement, are summarized in Table 2.
With regard to 9p deletion syndrome a critical region involved in
gonadal dysgenesis in XY patients has been proposed to reside at
9p24.3, from 9p telomere to the DMRT genes cluster (Barbaro et al.,
2009; Ogata et al., 1997). The phenotype of XY patients with terminal
9p deletions varies from complete sex reversal to milder phenotypes.
Genes belonging to DMRT1, 2 and 3 cluster have been proposed as
candidates, since they are involved in the vertebrate sex-
determining pathway and exhibit a gonad-speciﬁc expression pat-
tern. This 9p24.3 critical region is included in the deletion of our pa-
tient, who only shows bilateral cryptorchidism, a mild genital/
gonadal phenotype.
Different critical regions have been suggested for the consensus
phenotype associated to 9p deletion syndrome (Christ et al., 1999;
Faas et al., 2007; Kawara et al., 2006; Swinkles et al., 2008). The
ﬁrst, proposed in 1999 (Christ et al., 1999) is associated with devel-
opmental delay/mental retardation, trigonocephaly, midface hypo-
plasia and long philtrum. Subsequently, efforts to narrow down
the critical region have been attempted. Swinkles et al. (2008) pro-
posed a 300 kb long critical region in 9p22.3, while Faas et al.
(2007) and Kawara et al. (2006) proposed wider and more distally
extending regions in 9p23p22.3 (Fig. 3). Typical features of 9p
monosomy syndrome such as midface hypoplasia, hypertelorism,
long philtrum, anomalous auricles and broad neck are present in
our patient, but not micrognathia and up slanting palpebral ﬁssures.
Cardiac defects, inguinal hernia and scoliosis, all present in our case,
have been rarely observed (Swinkles et al., 2008). Trigonocephaly is
considered the most prominent feature of 9p deletion syndrome
consensus phenotype. This anomaly is not present in our patient, al-
though his deletion overlaps all critical regions proposed for the
9p deletion syndrome consensus phenotype. We speculate that his
duplicated region inﬂuenced the cranial features more than the
ﬂanking deletion. Indeed, in addition to the terminal deletion, our
patient carries an adjacent duplication involving the 9p22.2p11.2
segment. The 9p22 band has been proposed as the candidate region
for the consensus phenotype of the 9p duplication syndrome
(Fujimoto et al., 1998). Described patients had developmental delay/
mental retardation, small stature, microcephaly/brachycephaly,
down slanting palpebral ﬁssures, deep-set eyes, hypertelorism,
low-set ears, bulbous/prominent nose, downturned mouth and
limb anomalies (Fujimoto et al., 1998). Recently, Jelin et al. (2010)
characterized a 31.1 Mb duplication from 9p telomere to 9p21.1 in
a female patient showing in addition short philtrum, orofacial cleft-
ing and thoracic kyphosis. Duplications in 9p21.3p13.2 and in
9p22.3p21.1 in patients with milder dysmorphic features, growth
retardation and speech/language delay have been also reported
(Bonaglia et al., 2002; Zou et al., 2009). Interestingly, Stumm et al.
(2002) described a phenotypically normal male carrying an intersti-
tial duplication of 9p21p12, indicating in 9p21 band the distal
boundary of the critical region for 9p duplication syndrome. A mo-
saic supernumerary marker chromosome involving part of the short
arm of chromosome 9 has been described in a patient showing a
subset of the 9p duplication features, likely due to the mosaic na-
ture of the marker (Abu-Amero et al., 2010). Our patient manifests
brachycephaly, down slanting palpebral ﬁssures, hypertelorism,
low-set ears, bulbous/prominent nose and skeletal malformation.
Moreover, it is important to notice that cleft palate or other
palate malformations are described in all reviewed patients with
9p duplication except in the patients described by Zou et al.
(2009) and Abu-Amero et al. (2010), suggesting that a palate mal-
formation predisposing region may resides in 9p22.2p22.1 if
duplicated.The coexistence of partial 9p monosomy and trisomy has been de-
scribed in other cases discussed in the present paper (Fig. 3 and
Table 2) (Al Achkar et al., 2010; Hulik et al., 2009; Swinkles et al.,
2008). All show features shared by 9p deletion and 9p duplication
syndromes, such as developmental delay, psychomotor retardation,
hypotonia and low-set ears, but the manifestation of syndrome-
speciﬁc features is variable and depends on the length of the different
genomic regions involved. Among the 9p deletion dysmorphic fea-
tures, these cases share midface hypoplasia, thin upper lip, long phil-
trum and micrognatia and their deleted regions overlap about 3.7 Mb
of the 9p24.3p24.2 interval. Among the 9p duplication features they
share only bulbous nasal tip, and their duplications overlap about
1.8 Mb in 9p22.2p22.1 (Fig. 3 and Table 2).
Based on the UCSC database there are about 53 genes annotated
in the region deleted in our patient. Loss or mutation of a few
genes such as DOCK8, KANK1(ANKRD15), SLC1A1 and GLDC, has
been already associated with mental, motor retardation and/or
other neurological symptoms (Bailey et al., 2011; Griggs et al., 2008;
Lerer et al., 2005; Meyer et al., 2010), making their deletion likely re-
sponsible for the severe mental and motor delay of our patient. At
least 120 genes are located in the duplicated regions of our patient
and some may be dosage-sensitive thus contributing to the observed
phenotype.
Further studies providing for these patients a reﬁned molecular
cytogenetic characterization such as that performed in this study
are needed to appoint dosage sensitive genes of chromosome 9p
and assign the genes responsible for the developmental delay
and craniofacial dysmorphisms of our and previously reported pa-
tients. Genetic counselling aimed at assuring the best follow-up of
the patients would greatly beneﬁt of the increased understanding of
the genotype/phenotype correlations in such patients.
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.gene.2012.04.030.
References
Abu-Amero, K.K., et al., 2010. A de novo marker chromosome derived from 9p in a pa-
tient with 9p partial duplication syndrome and autism features: genotype–pheno-
type correlation. BMC Med. Genet. 11, 135.
Al Achkar, W., Wafa, A., Moassass, F., Liehr, T., 2010. Partial trisomy 9p22 to
9p24.2 in combination with partial monosomy 9pter in a Syrian girl. Mol. Cyto-
genet. 3, 18.
Bailey, C.G., et al., 2011. Loss-of-function mutations in the glutamate transporter
SLC1A1 cause human dicarboxylic aminoaciduria. J. Clin. Invest. 121, 446–453.
Barbaro, M., et al., 2009. Characterization of deletions at 9p affecting the candidate re-
gions for sex reversal and deletion 9p syndrome by MLPA. Eur. J. Hum. Genet. 17,
1439–1447.
Bonaglia, M.C., et al., 2002. 20 Mb duplication of chromosome 9p in a girl with minimal
physical ﬁndings and normal IQ: narrowing of the 9p duplication critical region to
6 Mb. Am. J. Med. Genet. 112, 154–159.
Christ, L.A., Crowe, C.A., Micale, M.A., Conroy, J.M., Schwartz, S., 1999. Chromosome
breakage hotspots delineation of the critical region for the 9p-deletion syndrome.
Am. J. Hum. Genet. 65, 1387–1395.
Faas, B.H.W., de Leeuw, N., Mieloo, H., Bruinenberg, J., de Vries, B.B.A., 2007. Further re-
ﬁnement of the candidate region for monosomy 9p syndrome. Am. J. Med. Genet. A
143, 2353–2356.
Fujimoto, A., Lin, M.S., Schwartz, S., 1998. Direct duplication of 9p22-p24 in a child with
duplication 9p syndrome. Am. J. Med. Genet. 77, 268–271.
Griggs, B.L., Ladd, S., Saul, R.A., DuPont, B.R., Srivastava, A.K., 2008. Dedicator of cytoki-
nesis 8 is disrupted in two patients with mental retardation and developmental
disabilities. Genomics 91, 195–202.
Hulik, P.J., et al., 2009. Cytogenetic and array-CGH characterization of a complex de
novo rearrangement involving duplication and deletion of 9p and clinical ﬁndings
in a 4-month-old female. Cytogenet. Genome Res. 126, 305–312.
Jelin, A., Perry, H., Hogue, J., Oberoi, S., Cotter, P.D., Klein, O.D., 2010. Clefting in trisomy
9p patients: genotype–phenotype correlation using microarray comparative geno-
mic hybridization. J. Craniofac. Surg. 21, 1376–1379.
Kawara, H., et al., 2006. Narrowing candidate region for monosomy 9p syndrome to 4.7
Mb segment at 9p22.2-p23. Am. J. Med. Genet. A 140, 373–377.
Lerer, I., Sagi, M., Meiner, V., Cohen, T., Zlotogora, J., Abeliovich, D., 2005. Deletion of the
ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial
cerebral palsy. Hum. Mol. Genet. 14, 3911–3920.
Lichter, P., Cremer, T., 1992. Chromosome analysis by non-isotopic in situ hybridiza-
tion. In: Rooney, D.E., Czipolkowski, B.H. (Eds.), Human Cytogen—A Practical
Approach. Oxford University Press, Oxford, pp. 157–192.
45M.P. Recalcati et al. / Gene 502 (2012) 40–45Meyer, S., Acquaviva, C., Shamdeen, M.G., Haas, D., Vianey-Saban, C., 2010. A novel mis-
sense mutation in a neonate with nonketotic hyperglycinemia. Pediatr. Neurol. 43,
363–367.
Ogata, T., Muroya, K., Matsuo, N., Hata, J., Fukushima, Y., Suzuki, Y., 1997. Impaired male
sex development in an infant with molecularly deﬁned partial 9p monosomy: im-
plication for a testis forming gene(s) on 9p. J. Med. Genet. 34, 331–334.
Shaffer, L.G., Slovak, M.L., 2009. ISCN 2009: An International System for Human Cytoge-
netic Nomenclature. S. Karger AG, Switzerland.Stumm, M., et al., 2002. Partial trisomy 9p12p21.3 with a normal phenotype. J. Med.
Genet. 39, 141–144.
Swinkles, M.E.M., et al., 2008. Clinical and cytogenetic characterization of 13 dutch pa-
tients with deletion 9p syndrome: delineation of the critical region for a consensus
phenotype. Am. J. Med. Genet. A 146, 1430–1438.
Zou, Y.S., Huang, X., Ito, M., Newton, S., Milunsky, J.M., 2009. Further delineation of
the critical region for the 9p-duplication syndrome. Am. J. Med. Genet. A 149,
272–276.
